You just read:

Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation® Technology to Develop Long-Acting Asparaginase Product Candidates

News provided by

Jazz Pharmaceuticals plc

Jul 26, 2017, 16:05 ET